SAA1 and acute myeloid leukemia: Considering the importance of SAA1 in HN and AML, with the aim of its use as a potential diagnostic biomarker for AML, we confirmed the increased expression of SAA1 through an ELISA with a large cohort of plasma samples from AML patients with different subtypes compared with a group of plasma samples from healthy donors.